- Filed
- May 5, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 43.2M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 42.4M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 45.51M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $3.81M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $666K |
| Capex | Q1 2026 · Mar 31, 2026 | $1.65M |
| Capex | Q1 2026 · Mar 31, 2025 | $2.16M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $8.41M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $2.25M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $33M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $30M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $3.01M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $2.91M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $92.52M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $94.51M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $57.2M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $55.08M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $99.48M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $93.74M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $25.44M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $24.48M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $192M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $188.24M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.04 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.21 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.04 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.21 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $6.77M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $7.2M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $3.08M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $3.84M |
| Net Income | Q1 2026 · Mar 31, 2026 | $1.53M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$9.75M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $3.06M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$9.28M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $4.76M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $5.37M |